The GL-2045 discovery program started when a family member of one of Gliknik’s founders needed IVIG

/in , /by

The GL-2045 discovery program started when a family member of one of Gliknik’s founders needed IVIG, a synthetic human blood product used to treat disorders of the immune system or to boost immune response to serious illness.